- Home
- ACTU vs MCN Comparison
ACTU vs MCN Comparison
Compare ACTU & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- MCN
- Stock Information
- Founded
- ACTU 2015
- MCN 2004
- Country
- ACTU United States
- MCN Canada
- Employees
- ACTU N/A
- MCN N/A
- Industry
- ACTU
- MCN
- Sector
- ACTU
- MCN
- Exchange
- ACTU NYSE
- MCN Nasdaq
- Market Cap
- ACTU 135.0M
- MCN 115.9M
- IPO Year
- ACTU 2024
- MCN N/A
- Fundamental
- Price
- ACTU $11.25
- MCN $6.03
- Analyst Decision
- ACTU Strong Buy
- MCN
- Analyst Count
- ACTU 1
- MCN 0
- Target Price
- ACTU $20.00
- MCN N/A
- AVG Volume (30 Days)
- ACTU 68.4K
- MCN 52.9K
- Earning Date
- ACTU 05-15-2025
- MCN 01-01-0001
- Dividend Yield
- ACTU N/A
- MCN 9.96%
- EPS Growth
- ACTU N/A
- MCN N/A
- EPS
- ACTU N/A
- MCN N/A
- Revenue
- ACTU N/A
- MCN N/A
- Revenue This Year
- ACTU N/A
- MCN N/A
- Revenue Next Year
- ACTU N/A
- MCN N/A
- P/E Ratio
- ACTU N/A
- MCN N/A
- Revenue Growth
- ACTU N/A
- MCN N/A
- 52 Week Low
- ACTU $5.51
- MCN $6.69
- 52 Week High
- ACTU $11.99
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- MCN 60.57
- Support Level
- ACTU N/A
- MCN $5.90
- Resistance Level
- ACTU N/A
- MCN $6.02
- Average True Range (ATR)
- ACTU 0.00
- MCN 0.08
- MACD
- ACTU 0.00
- MCN -0.00
- Stochastic Oscillator
- ACTU 0.00
- MCN 41.94
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.